Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Netramark Holdings Inc. Stock

Price
Target price
€0.60

€0.60

7.560%
0.045
7.560%
-
 
03.03.26 / Tradegate WKN: A3D5X9 / Name: Netramark Holdings / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Netramark Holdings Inc. in the next few years
Wizard

Financial data and news for Netramark Holdings

sharewise wants to provide you with the best news and tools for Netramark Holdings, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

NetraMark Delivers Transformational Quarter of Execution
NetraMark Delivers Transformational Quarter of Execution

Contract Backlog Expands to C$2.5M, FDA CPIM Completed, Nature Portfolio Study Accepted, Major Channel Partner Onboarding, and CAMH Research Award Secured

 

TORONTO, ON, December 18, 2025 –

irwpresse_en 
0 18.12.25
NetraMark Achieves Major FDA Milestone
NetraMark Achieves Major FDA Milestone

TORONTO, ON, December 15, 2025 – NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is

irwpresse_en 
0 15.12.25
NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio
NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio

TORONTO, ON, December 8, 2025 – NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is

irwpresse_en 
0 08.12.25
NetraMark Signs Four New Contracts with a Leading Global Pharmaceutical Company to Enhance Clinical Trial Insights
NetraMark Signs Four New Contracts with a Leading Global Pharmaceutical Company to Enhance Clinical Trial Insights

TORONTO, ON, November 18, 2025 – NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company

irwpresse_en 
0 18.11.25
NetraMark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights
NetraMark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

TORONTO, ON, November 3, 2025 – NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is

irwpresse_en 
0 03.11.25
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research

TORONTO, ON, September 22, 2025 – NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is

irwpresse_en 
0 22.09.25